Archive for the ‘Cardio Vascular System’ Category
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Posted by: admin on: March 7, 2012
Statins have been the drug of choice for prevention of cardiovascular events in high risk patients. This study on statins further reiterates its efficacy and also compares the effects of the two frequently used statins. Team@CMHF
ACC/AHA updates secondary-prevention guidelines without new BP and lipid guidance
Posted by: admin on: March 6, 2012
With more emphasis on prevention than cure AHA has come out with new guidelines which are easy on the CAD patients in order to prevent cardiovascular events or reduce such risks on these patients. Team@CMHF
New ESC Guidelines on diagnosis and treatment of peripheral artery disease
Posted by: admin on: March 5, 2012
With geriatric population on the rise atherosclerotic disease is a major problem faced by the physicians. Atherosclerosis which hits the coronary arteries can also affect other vascular areas leading to PAD. Here is something about the guidelines that is being introduced. Team@CMHF
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
Posted by: admin on: March 1, 2012
Niacin added to statin therapy gave significant improvement on HDL and Triglyceride levels but had no added effect on LDL levels says a report. Team@CMHF
Azilsartan Medoxomil: A New Angiotensin Receptor Blocker
Posted by: admin on: February 29, 2012
Azilsartan is a new drug successfully tried on adults and now being studied on pediatric group. Here is what the study on adults has to say. Team@CMHF
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
